These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 874793)

  • 21. Determination of sematilide in plasma by high-performance liquid chromatography.
    Dancik S; Koziol T; Nisperos E; Woolf E
    J Pharm Sci; 1991 Feb; 80(2):157-9. PubMed ID: 2051320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Letter: Fluorometric or gas-liquid chromatographic determination of procainamide?
    Frislid K; Bredesen JE; Lunde PK
    Clin Chem; 1975 Jul; 21(8):1180-2. PubMed ID: 1137928
    [No Abstract]   [Full Text] [Related]  

  • 23. Liquid chromatographic analysis of mexiletine in serum, with alternate application to tocainide, procainamide, and N-acetylprocainamide.
    vasBinder E; Annesley T
    Biomed Chromatogr; 1991 Jan; 5(1):19-22. PubMed ID: 1709575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The formation of procainamide hydroxylamine by rat and human liver microsomes.
    Budinsky RA; Roberts SM; Coats EA; Adams L; Hess EV
    Drug Metab Dispos; 1987; 15(1):37-43. PubMed ID: 2881757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longer plasma half-life for procainamide utilizing a very sensitive high performance liquid chromatography assay.
    Jamali F; Alballa RS; Mehvar R; Lemko CH
    Ther Drug Monit; 1988; 10(1):91-6. PubMed ID: 2453956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of very rapid emit Qst methods for measuring serum procainamide and N-acetylprocainamide concentrations.
    Carnes CA; Coyle JD
    Pharmacotherapy; 1992; 12(1):40-4. PubMed ID: 1372425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug polymer combinations. V. High performance liquid chromatographic determination and pharmacokinetic behaviour of the methacrylamide of procainamide.
    Gyselinck P; Van Severen R; Braeckman P; Schacht E
    J Pharm Belg; 1981; 36(3):200-2. PubMed ID: 7264867
    [No Abstract]   [Full Text] [Related]  

  • 28. Thin-layer chromatographic determination of procainamide and N-acetylprocainamide in human serum and urine at single-dose levels.
    Kark B; Sistovaris N; Keller A
    J Chromatogr; 1983 Oct; 277():261-72. PubMed ID: 6196373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A high performance liquid chromatographic assay for tocainide with alternate application for the determination of lidocaine, procainamide, and N-acetylprocainamide.
    Annesley T; Matz K; Davenport R; Giacherio D
    Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):173-81. PubMed ID: 2421377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Steady-state plasma and saliva concentrations of procainamide and N-acetyl-procainamide after a sustained release preparation].
    Pirovino M; Karlaganis G; Galeazzi RL
    Schweiz Med Wochenschr; 1980 Sep; 110(39):1415-9. PubMed ID: 6169144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative thin-layer chromatographic method for the determination of procainamide and its major metabolite in plasma.
    Wesley-Hadzija B; Mattocks AM
    J Chromatogr; 1977 May; 143(3):307-13. PubMed ID: 863987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorescence photometric quantitation of procainamide and N-acetylprocainamide in plasma after separation by thin-layer chromatography.
    Gupta RN; Eng F; Lewis D
    Anal Chem; 1978 Feb; 50(2):197-9. PubMed ID: 623381
    [No Abstract]   [Full Text] [Related]  

  • 33. Simultaneous determination of procainamide and N-acetylprocainamide in serum by gas chromatography with nitrogen-selective detection.
    Yamaji A; Kataoka K; Oishi M; Kanamori N; Hiraoka E; Mishima M
    J Chromatogr; 1987 Mar; 415(1):143-7. PubMed ID: 2438294
    [No Abstract]   [Full Text] [Related]  

  • 34. The pharmacokinetics of procainamide in normal subjects using a specific gas chromatographic assay.
    Simons KJ; Levy RH; Cutler RE; Christopher GT; Lindner A
    Res Commun Chem Pathol Pharmacol; 1975 Jun; 11(2):173-85. PubMed ID: 1153866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Procainamide interference with liquid chromatography of theophylline in serum.
    Marion A; Lesko LJ; Oliver C
    Ther Drug Monit; 1981; 3(1):107-8. PubMed ID: 7233485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversed-phase liquid chromatography method for measurement of procainamide and three metabolites in serum and urine: percent of dose excreted as deethyl metabolites.
    Coyle JD; MacKichan JJ; Boudoulas H; Lima JJ
    J Pharm Sci; 1987 May; 76(5):402-5. PubMed ID: 2443639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorometric assay for N-acetylprocainamide.
    Matusik E; Gibson TP
    Clin Chem; 1975 Dec; 21(13):1899-902. PubMed ID: 160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of renal clearance using arterial and venous plasma: procainamide in rabbits.
    Lam G; Chiou WL
    J Pharm Sci; 1981 Dec; 70(12):1373-5. PubMed ID: 7320857
    [No Abstract]   [Full Text] [Related]  

  • 39. Determination of metabolically derived nitroprocainamide in the urine of procainamide-dosed humans and rats by liquid chromatography with electrochemical detection.
    Wheeler JF; Adams LE; Mongey AB; Roberts SM; Heineman WR; Hess EV
    Drug Metab Dispos; 1991; 19(3):691-5. PubMed ID: 1680638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiarrhythmic potency of N-acetylprocainamide.
    Elson J; Strong JM; Lee WK; Atkinson AJ
    Clin Pharmacol Ther; 1975 Feb; 17(2):134-40. PubMed ID: 1122675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.